Prognostic and clinical significance of metastasis-associated gene 1 overexpression in solid cancers: A meta-analysis
In the past 2 decades, metastasis-associated gene 1 (MTA1) has attracted attention for its close association with cancer progression and its roles in chromatin remodeling processes, making it a central gene in cancer. The present meta-analysis was performed to assess MTA1 expression in solid tumors....
Gespeichert in:
| Veröffentlicht in: | Medicine (Baltimore) 2018-10, Vol.97 (41), p.e12292-e12292 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e12292 |
|---|---|
| container_issue | 41 |
| container_start_page | e12292 |
| container_title | Medicine (Baltimore) |
| container_volume | 97 |
| creator | Ma, Ke Fan, Yangwei Hu, Yuan |
| description | In the past 2 decades, metastasis-associated gene 1 (MTA1) has attracted attention for its close association with cancer progression and its roles in chromatin remodeling processes, making it a central gene in cancer. The present meta-analysis was performed to assess MTA1 expression in solid tumors.
This analysis identified studies that evaluated the relationship between MTA1 expression and clinical characteristics or prognosis of patients with solid tumors via the PubMed, Cochrane Library, and Embase electronic databases. Fixed-effect and random-effect meta-analytical techniques were used to correlate MTA1 expression with outcome measures. The outcome variables are shown as odds ratio (OR) or hazard ratio (HR) with 95% confidence interval (CI).
Analysis of 40 cohort studies involving 4564 cancer patients revealed a significant association of MTA1 overexpression with tumor patient age (>50 vs. 3 cm vs. |
| doi_str_mv | 10.1097/MD.0000000000012292 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6203568</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2119930074</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2859-5eb0f44a8f6da83cbb30df44a42a3c2885fe08e4c4678076a758c95280dd3db53</originalsourceid><addsrcrecordid>eNpdkV1vFCEUhonR2LX6C0wMl95M5XMAL0ya1q-kjV7oNWGYM7soCyvMtPbfy3Zr_SAkkMPzPhAOQs8pOaHEqFeX5yfkz6CMGfYArajkfSdNLx6iFSFMdsoocYSe1PqtQVwx8RgdccIpJ0yt0PK55HXKdQ4euzRiH0MK3kVcwzqFqW2TB5wnvIXZ1TZD7Vyt2Qc3w4jXkABTnK-gwM9dgVpDTjgkXHMMzbZPl_oan97mO5dcvGmKp-jR5GKFZ3frMfr67u2Xsw_dxaf3H89OLzrPtDSdhIFMQjg99aPT3A8DJ-O-IJjjDdFyAqJBeNErTVTvlNTeSKbJOPJxkPwYvTl4d8uwhdFDmouLdlfC1pUbm12w_56ksLHrfGV7RrjsdRO8vBOU_GOBOtttqB5idAnyUi2j1BhOiBIN5QfUl1xrgen-GkrsvmH28tz-37CWevH3C-8zvzvUAHEArnOc219-j8s1FLsBF-fNrU8qwzpGqKbNSbp9yfBf3eOjHg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2119930074</pqid></control><display><type>article</type><title>Prognostic and clinical significance of metastasis-associated gene 1 overexpression in solid cancers: A meta-analysis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wolters Kluwer Open Health</source><source>IngentaConnect Free/Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Ma, Ke ; Fan, Yangwei ; Hu, Yuan</creator><creatorcontrib>Ma, Ke ; Fan, Yangwei ; Hu, Yuan</creatorcontrib><description>In the past 2 decades, metastasis-associated gene 1 (MTA1) has attracted attention for its close association with cancer progression and its roles in chromatin remodeling processes, making it a central gene in cancer. The present meta-analysis was performed to assess MTA1 expression in solid tumors.
This analysis identified studies that evaluated the relationship between MTA1 expression and clinical characteristics or prognosis of patients with solid tumors via the PubMed, Cochrane Library, and Embase electronic databases. Fixed-effect and random-effect meta-analytical techniques were used to correlate MTA1 expression with outcome measures. The outcome variables are shown as odds ratio (OR) or hazard ratio (HR) with 95% confidence interval (CI).
Analysis of 40 cohort studies involving 4564 cancer patients revealed a significant association of MTA1 overexpression with tumor patient age (>50 vs. <50 years: combined OR 0.73, 95% CI 0.57-0.94), tumor grade (G3/4 vs. G1/2: combined OR 1.94, 95% CI 1.48-2.53), tumor size (>3 cm vs. <3 cm: combined OR 2.35, 95% CI 1.73-3.19), T stage (T3/4 vs. T1/2: combined OR 2.11, 95% CI 1.74-2.56), lymph node metastasis (yes vs. no: combined OR 2.92, 95% CI 2.26-3.75), distant metastasis (yes vs. no: combined OR 2.26, 95% CI 1.42-3.59), TNM stage (III/IV vs. I/II: combined OR 2.50, 95% CI 1.84-3.38), vascular invasion (yes vs. no: combined OR 2.26, 95% CI 1.92-3.56), and poor overall survival time (HR 1.83; 95% CI: 1.53-2.20; P = .000).
Our analyses demonstrate that MTA1 was an effective predictor of a worse prognosis in tumor patients. Moreover, MTA1 may play important role in tumor progression and outcome, and targeting MTA1 may be a new strategy for anti-cancer therapy.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000012292</identifier><identifier>PMID: 30313027</identifier><language>eng</language><publisher>United States: the Author(s). Published by Wolters Kluwer Health, Inc</publisher><subject>Biomarkers, Tumor - metabolism ; Histone Deacetylases - metabolism ; Humans ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Neoplasms - diagnosis ; Neoplasms - metabolism ; Neoplasms - mortality ; Neoplasms - pathology ; Odds Ratio ; Prognosis ; Repressor Proteins - metabolism ; Survival Rate ; Systematic Review and Meta-Analysis ; Trans-Activators ; Up-Regulation</subject><ispartof>Medicine (Baltimore), 2018-10, Vol.97 (41), p.e12292-e12292</ispartof><rights>the Author(s). Published by Wolters Kluwer Health, Inc.</rights><rights>Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2859-5eb0f44a8f6da83cbb30df44a42a3c2885fe08e4c4678076a758c95280dd3db53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203568/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203568/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30313027$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Ke</creatorcontrib><creatorcontrib>Fan, Yangwei</creatorcontrib><creatorcontrib>Hu, Yuan</creatorcontrib><title>Prognostic and clinical significance of metastasis-associated gene 1 overexpression in solid cancers: A meta-analysis</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>In the past 2 decades, metastasis-associated gene 1 (MTA1) has attracted attention for its close association with cancer progression and its roles in chromatin remodeling processes, making it a central gene in cancer. The present meta-analysis was performed to assess MTA1 expression in solid tumors.
This analysis identified studies that evaluated the relationship between MTA1 expression and clinical characteristics or prognosis of patients with solid tumors via the PubMed, Cochrane Library, and Embase electronic databases. Fixed-effect and random-effect meta-analytical techniques were used to correlate MTA1 expression with outcome measures. The outcome variables are shown as odds ratio (OR) or hazard ratio (HR) with 95% confidence interval (CI).
Analysis of 40 cohort studies involving 4564 cancer patients revealed a significant association of MTA1 overexpression with tumor patient age (>50 vs. <50 years: combined OR 0.73, 95% CI 0.57-0.94), tumor grade (G3/4 vs. G1/2: combined OR 1.94, 95% CI 1.48-2.53), tumor size (>3 cm vs. <3 cm: combined OR 2.35, 95% CI 1.73-3.19), T stage (T3/4 vs. T1/2: combined OR 2.11, 95% CI 1.74-2.56), lymph node metastasis (yes vs. no: combined OR 2.92, 95% CI 2.26-3.75), distant metastasis (yes vs. no: combined OR 2.26, 95% CI 1.42-3.59), TNM stage (III/IV vs. I/II: combined OR 2.50, 95% CI 1.84-3.38), vascular invasion (yes vs. no: combined OR 2.26, 95% CI 1.92-3.56), and poor overall survival time (HR 1.83; 95% CI: 1.53-2.20; P = .000).
Our analyses demonstrate that MTA1 was an effective predictor of a worse prognosis in tumor patients. Moreover, MTA1 may play important role in tumor progression and outcome, and targeting MTA1 may be a new strategy for anti-cancer therapy.</description><subject>Biomarkers, Tumor - metabolism</subject><subject>Histone Deacetylases - metabolism</subject><subject>Humans</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasms - diagnosis</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - mortality</subject><subject>Neoplasms - pathology</subject><subject>Odds Ratio</subject><subject>Prognosis</subject><subject>Repressor Proteins - metabolism</subject><subject>Survival Rate</subject><subject>Systematic Review and Meta-Analysis</subject><subject>Trans-Activators</subject><subject>Up-Regulation</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkV1vFCEUhonR2LX6C0wMl95M5XMAL0ya1q-kjV7oNWGYM7soCyvMtPbfy3Zr_SAkkMPzPhAOQs8pOaHEqFeX5yfkz6CMGfYArajkfSdNLx6iFSFMdsoocYSe1PqtQVwx8RgdccIpJ0yt0PK55HXKdQ4euzRiH0MK3kVcwzqFqW2TB5wnvIXZ1TZD7Vyt2Qc3w4jXkABTnK-gwM9dgVpDTjgkXHMMzbZPl_oan97mO5dcvGmKp-jR5GKFZ3frMfr67u2Xsw_dxaf3H89OLzrPtDSdhIFMQjg99aPT3A8DJ-O-IJjjDdFyAqJBeNErTVTvlNTeSKbJOPJxkPwYvTl4d8uwhdFDmouLdlfC1pUbm12w_56ksLHrfGV7RrjsdRO8vBOU_GOBOtttqB5idAnyUi2j1BhOiBIN5QfUl1xrgen-GkrsvmH28tz-37CWevH3C-8zvzvUAHEArnOc219-j8s1FLsBF-fNrU8qwzpGqKbNSbp9yfBf3eOjHg</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Ma, Ke</creator><creator>Fan, Yangwei</creator><creator>Hu, Yuan</creator><general>the Author(s). Published by Wolters Kluwer Health, Inc</general><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20181001</creationdate><title>Prognostic and clinical significance of metastasis-associated gene 1 overexpression in solid cancers: A meta-analysis</title><author>Ma, Ke ; Fan, Yangwei ; Hu, Yuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2859-5eb0f44a8f6da83cbb30df44a42a3c2885fe08e4c4678076a758c95280dd3db53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Biomarkers, Tumor - metabolism</topic><topic>Histone Deacetylases - metabolism</topic><topic>Humans</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasms - diagnosis</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - mortality</topic><topic>Neoplasms - pathology</topic><topic>Odds Ratio</topic><topic>Prognosis</topic><topic>Repressor Proteins - metabolism</topic><topic>Survival Rate</topic><topic>Systematic Review and Meta-Analysis</topic><topic>Trans-Activators</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ma, Ke</creatorcontrib><creatorcontrib>Fan, Yangwei</creatorcontrib><creatorcontrib>Hu, Yuan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Ke</au><au>Fan, Yangwei</au><au>Hu, Yuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic and clinical significance of metastasis-associated gene 1 overexpression in solid cancers: A meta-analysis</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2018-10-01</date><risdate>2018</risdate><volume>97</volume><issue>41</issue><spage>e12292</spage><epage>e12292</epage><pages>e12292-e12292</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>In the past 2 decades, metastasis-associated gene 1 (MTA1) has attracted attention for its close association with cancer progression and its roles in chromatin remodeling processes, making it a central gene in cancer. The present meta-analysis was performed to assess MTA1 expression in solid tumors.
This analysis identified studies that evaluated the relationship between MTA1 expression and clinical characteristics or prognosis of patients with solid tumors via the PubMed, Cochrane Library, and Embase electronic databases. Fixed-effect and random-effect meta-analytical techniques were used to correlate MTA1 expression with outcome measures. The outcome variables are shown as odds ratio (OR) or hazard ratio (HR) with 95% confidence interval (CI).
Analysis of 40 cohort studies involving 4564 cancer patients revealed a significant association of MTA1 overexpression with tumor patient age (>50 vs. <50 years: combined OR 0.73, 95% CI 0.57-0.94), tumor grade (G3/4 vs. G1/2: combined OR 1.94, 95% CI 1.48-2.53), tumor size (>3 cm vs. <3 cm: combined OR 2.35, 95% CI 1.73-3.19), T stage (T3/4 vs. T1/2: combined OR 2.11, 95% CI 1.74-2.56), lymph node metastasis (yes vs. no: combined OR 2.92, 95% CI 2.26-3.75), distant metastasis (yes vs. no: combined OR 2.26, 95% CI 1.42-3.59), TNM stage (III/IV vs. I/II: combined OR 2.50, 95% CI 1.84-3.38), vascular invasion (yes vs. no: combined OR 2.26, 95% CI 1.92-3.56), and poor overall survival time (HR 1.83; 95% CI: 1.53-2.20; P = .000).
Our analyses demonstrate that MTA1 was an effective predictor of a worse prognosis in tumor patients. Moreover, MTA1 may play important role in tumor progression and outcome, and targeting MTA1 may be a new strategy for anti-cancer therapy.</abstract><cop>United States</cop><pub>the Author(s). Published by Wolters Kluwer Health, Inc</pub><pmid>30313027</pmid><doi>10.1097/MD.0000000000012292</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0025-7974 |
| ispartof | Medicine (Baltimore), 2018-10, Vol.97 (41), p.e12292-e12292 |
| issn | 0025-7974 1536-5964 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6203568 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wolters Kluwer Open Health; IngentaConnect Free/Open Access Journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Biomarkers, Tumor - metabolism Histone Deacetylases - metabolism Humans Neoplasm Invasiveness Neoplasm Metastasis Neoplasms - diagnosis Neoplasms - metabolism Neoplasms - mortality Neoplasms - pathology Odds Ratio Prognosis Repressor Proteins - metabolism Survival Rate Systematic Review and Meta-Analysis Trans-Activators Up-Regulation |
| title | Prognostic and clinical significance of metastasis-associated gene 1 overexpression in solid cancers: A meta-analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T09%3A07%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20and%20clinical%20significance%20of%20metastasis-associated%20gene%201%20overexpression%20in%20solid%20cancers:%20A%20meta-analysis&rft.jtitle=Medicine%20(Baltimore)&rft.au=Ma,%20Ke&rft.date=2018-10-01&rft.volume=97&rft.issue=41&rft.spage=e12292&rft.epage=e12292&rft.pages=e12292-e12292&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000012292&rft_dat=%3Cproquest_pubme%3E2119930074%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2119930074&rft_id=info:pmid/30313027&rfr_iscdi=true |